Dianthus reports Q2 EPS (51c), consensus (55c)
PremiumThe FlyDianthus reports Q2 EPS (51c), consensus (55c)
3M ago
Dianthus initiated with an Outperform at Baird
Premium
The Fly
Dianthus initiated with an Outperform at Baird
3M ago
Two new option listings on July 9th
Premium
The Fly
Two new option listings on July 9th
4M ago
Dianthus Therapeutics Presents Future Outlook at Conference
PremiumCompany AnnouncementsDianthus Therapeutics Presents Future Outlook at Conference
5M ago
Dianthus Therapeutics Enhances Incentives and Affirms Governance
Premium
Company Announcements
Dianthus Therapeutics Enhances Incentives and Affirms Governance
5M ago
Intel upgraded, Texas Instruments initiated: Wall Street’s top analyst calls
Premium
The Fly
Intel upgraded, Texas Instruments initiated: Wall Street’s top analyst calls
6M ago
Dianthus announces oral presentation for DNTH103
PremiumThe FlyDianthus announces oral presentation for DNTH103
7M ago
Drugmakers look to alternative suppliers after draft U.S. legislation, FT says
Premium
The Fly
Drugmakers look to alternative suppliers after draft U.S. legislation, FT says
7M ago
Dianthus Therapeutics’ High-Stakes Gamble: Navigating Regulatory Risks and Supplier Challenges in Novel Drug Delivery
Premium
Company Announcements
Dianthus Therapeutics’ High-Stakes Gamble: Navigating Regulatory Risks and Supplier Challenges in Novel Drug Delivery
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100